KR20190041776A - Health tea composition and health tea using medicinal herbs - Google Patents
Health tea composition and health tea using medicinal herbs Download PDFInfo
- Publication number
- KR20190041776A KR20190041776A KR1020170133432A KR20170133432A KR20190041776A KR 20190041776 A KR20190041776 A KR 20190041776A KR 1020170133432 A KR1020170133432 A KR 1020170133432A KR 20170133432 A KR20170133432 A KR 20170133432A KR 20190041776 A KR20190041776 A KR 20190041776A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- mixture
- health tea
- ginseng
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 61
- 230000036541 health Effects 0.000 title claims abstract description 39
- 235000008216 herbs Nutrition 0.000 title abstract 3
- 241001122767 Theaceae Species 0.000 title 2
- 244000269722 Thea sinensis Species 0.000 claims abstract description 55
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 14
- 235000008397 ginger Nutrition 0.000 claims abstract description 14
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 7
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 6
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 6
- 235000013616 tea Nutrition 0.000 claims description 36
- 235000008434 ginseng Nutrition 0.000 claims description 22
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 21
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 21
- 235000009569 green tea Nutrition 0.000 claims description 16
- 229910052573 porcelain Inorganic materials 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 7
- 244000013123 dwarf bean Species 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 241001474374 Blennius Species 0.000 claims description 5
- 241000287828 Gallus gallus Species 0.000 claims description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 5
- 235000013361 beverage Nutrition 0.000 claims description 5
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 claims description 5
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 4
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 4
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 4
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 4
- 235000008708 Morus alba Nutrition 0.000 claims description 4
- 240000000249 Morus alba Species 0.000 claims description 4
- 235000006533 astragalus Nutrition 0.000 claims description 4
- 235000021331 green beans Nutrition 0.000 claims description 4
- 229940010454 licorice Drugs 0.000 claims description 4
- 235000013976 turmeric Nutrition 0.000 claims description 4
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 3
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 3
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 3
- 235000011511 Diospyros Nutrition 0.000 claims description 3
- 244000236655 Diospyros kaki Species 0.000 claims description 3
- 241000411851 herbal medicine Species 0.000 claims description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 2
- 241000723346 Cinnamomum camphora Species 0.000 claims description 2
- 241000195955 Equisetum hyemale Species 0.000 claims description 2
- 229960000846 camphor Drugs 0.000 claims description 2
- 229930008380 camphor Natural products 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 2
- 241001105098 Angelica keiskei Species 0.000 claims 1
- 240000004670 Glycyrrhiza echinata Species 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 13
- 230000002265 prevention Effects 0.000 abstract description 4
- 244000197580 Poria cocos Species 0.000 abstract description 3
- 235000008599 Poria cocos Nutrition 0.000 abstract description 3
- 241000121157 Achyranthes japonica Species 0.000 abstract description 2
- 235000013073 Acorus gramineus Nutrition 0.000 abstract description 2
- 244000001632 Acorus gramineus Species 0.000 abstract description 2
- FBMORZZOJSDNRQ-GLQYFDAESA-N Atractylenolide III Chemical compound C=C([C@@H]1C2)CCC[C@]1(C)C[C@@]1(O)C2=C(C)C(=O)O1 FBMORZZOJSDNRQ-GLQYFDAESA-N 0.000 abstract description 2
- 241000132011 Atractylodes lancea Species 0.000 abstract description 2
- 241000336291 Cistanche deserticola Species 0.000 abstract description 2
- 241000533367 Cnidium officinale Species 0.000 abstract description 2
- 244000089698 Zanthoxylum simulans Species 0.000 abstract description 2
- 210000000582 semen Anatomy 0.000 abstract description 2
- 239000001841 zingiber officinale Substances 0.000 abstract description 2
- 244000134552 Plantago ovata Species 0.000 abstract 1
- 235000003421 Plantago ovata Nutrition 0.000 abstract 1
- 239000009223 Psyllium Substances 0.000 abstract 1
- 241000508715 Ziziphus jujuba var. inermis Species 0.000 abstract 1
- 229940070687 psyllium Drugs 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 23
- 240000004371 Panax ginseng Species 0.000 description 17
- 208000024891 symptom Diseases 0.000 description 9
- 230000003412 degenerative effect Effects 0.000 description 8
- 241000234314 Zingiber Species 0.000 description 7
- 244000294611 Punica granatum Species 0.000 description 6
- 235000014360 Punica granatum Nutrition 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 208000024827 Alzheimer disease Diseases 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 241000255789 Bombyx mori Species 0.000 description 4
- 208000010877 cognitive disease Diseases 0.000 description 4
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000018865 Angelica gigas Nutrition 0.000 description 3
- 240000001810 Angelica gigas Species 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 229960001685 tacrine Drugs 0.000 description 3
- YLJREFDVOIBQDA-UHFFFAOYSA-N tacrine Chemical compound C1=CC=C2C(N)=C(CCCC3)C3=NC2=C1 YLJREFDVOIBQDA-UHFFFAOYSA-N 0.000 description 3
- 235000011330 Armoracia rusticana Nutrition 0.000 description 2
- 240000003291 Armoracia rusticana Species 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 241000282994 Cervidae Species 0.000 description 2
- 208000028698 Cognitive impairment Diseases 0.000 description 2
- 235000002787 Coriandrum sativum Nutrition 0.000 description 2
- 244000018436 Coriandrum sativum Species 0.000 description 2
- 241000759833 Cornus officinalis Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000202807 Glycyrrhiza Species 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 240000002045 Guettarda speciosa Species 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- 244000241872 Lycium chinense Species 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- XSVMFMHYUFZWBK-NSHDSACASA-N Rivastigmine Chemical compound CCN(C)C(=O)OC1=CC=CC([C@H](C)N(C)C)=C1 XSVMFMHYUFZWBK-NSHDSACASA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 201000004810 Vascular dementia Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000004195 gingiva Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000509537 Alisma canaliculatum Species 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 240000002470 Amphicarpaea bracteata Species 0.000 description 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
- 235000003276 Apios tuberosa Nutrition 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 241000052797 Arisaema amurense var. serratum Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 235000009292 Asparagus cochinchinensis Nutrition 0.000 description 1
- 244000248539 Asparagus cochinchinensis Species 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 206010048909 Boredom Diseases 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 241000723438 Cercidiphyllum japonicum Species 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 229940122041 Cholinesterase inhibitor Drugs 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000209020 Cornus Species 0.000 description 1
- 241001609679 Cuscuta japonica Species 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 235000002723 Dioscorea alata Nutrition 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000007056 Dioscorea composita Nutrition 0.000 description 1
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 1
- 235000005362 Dioscorea floribunda Nutrition 0.000 description 1
- 235000004868 Dioscorea macrostachya Nutrition 0.000 description 1
- 235000005361 Dioscorea nummularia Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 description 1
- 244000281702 Dioscorea villosa Species 0.000 description 1
- 241001481760 Erethizon dorsatum Species 0.000 description 1
- 229940122601 Esterase inhibitor Drugs 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241000224466 Giardia Species 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 235000002598 Inula helenium Nutrition 0.000 description 1
- 244000116484 Inula helenium Species 0.000 description 1
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241001532026 Liriope muscari Species 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000009668 Neurobehavioral Manifestations Diseases 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 235000001560 Prosopis chilensis Nutrition 0.000 description 1
- 240000007909 Prosopis juliflora Species 0.000 description 1
- 235000014460 Prosopis juliflora var juliflora Nutrition 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 241001618268 Rubus schizostylus Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 235000013030 Voandzeia subterranea Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940039856 aricept Drugs 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 208000013404 behavioral symptom Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 230000006949 cholinergic function Effects 0.000 description 1
- 210000002932 cholinergic neuron Anatomy 0.000 description 1
- 239000000544 cholinesterase inhibitor Substances 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960003530 donepezil Drugs 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000002329 esterase inhibitor Substances 0.000 description 1
- 229940108366 exelon Drugs 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000007924 ground bean Nutrition 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012907 medicinal substance Substances 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 208000027061 mild cognitive impairment Diseases 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000016273 neuron death Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229960004136 rivastigmine Drugs 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 235000008979 vitamin B4 Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/30—Further treatment of dried tea extract; Preparations produced thereby, e.g. instant tea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2112—Curcumin, turmeric
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/214—Tea
Abstract
Description
본 발명은 한약재를 이용한 건강차 조성물 및 건강차에 관한 것으로서, 특히 치매 예방 및 치료에 효과가 있는 건강차 조성물 및 건강차에 관한 것이다.The present invention relates to a health tea composition and a health tea using the medicinal herb, and more particularly, to a health tea composition and a health tea which are effective for the prevention and treatment of dementia.
치매(dementia)는 일상생활에 손상을 주는 기억과 인지능력의 점차적인 약화 현상으로, 크게 혈관성 치매와 퇴행성 치매로 구분할 수 있다. 혈관성 치매는 주로 혈관 내에 형성된 혈전에 의해 뇌출혈 또는 뇌졸중 등이 발생하는 경우가 해당되며 발병 주변 뇌세포가 상해를 입어 기억력 상실 증상 등이 유발된다. 반면 퇴행성 치매는 소위 알츠하이머성 치매로도 일컬어지는 것으로 β-아밀로이드가 포함된 노인반과 신경섬유다발이 형성되어 콜린성 신경을 포함하는 광범위한 신경을 사멸시키는 퇴행성 병변을 야기한다. 상기 신경 사멸이 일어나는 기전에 대해서는 활성산소종의 연관이 유력시되고 있다.Dementia is a gradual weakening of memory and cognitive abilities that damage daily life, and can be broadly divided into vascular dementia and degenerative dementia. Vascular dementia is usually caused by a blood clot formed in the blood vessels, such as cerebral hemorrhage or stroke, and the brain cells around the onset of injury caused by symptoms such as memory loss. On the other hand, degenerative dementia, also called Alzheimer's dementia, forms a bundle of nervous fibers and nervous fibers containing β-amyloid, resulting in degenerative lesions that kill a wide nerve, including the cholinergic nerve. The mechanism of the neuronal death is strongly related to the active oxygen species.
활성산소종이 노화의 원인이라는 가설이 1956년경에 제시된 이후 이들의 생성, 역할 및 작용 경로에 대한 연구가 이루어졌으며 활성산소종을 제거하는 항산화작용 물질의 개발에 관심이 집중되어 왔다. 퇴행성 치매를 가진 환자 사체의 뇌조직에 전시냅스(presynapse) 콜린 신경의 퇴화와 손실을 확인하였으며, 실제 퇴행성 치매 환자의 중추 콜린 기능이 강화될 때 인지력 손상이 개선된 결과가 보고되었다.Since the hypothesis that active oxygen species is the cause of aging has been suggested since 1956, their production, roles and pathways have been studied and attention has been focused on the development of antioxidant substances that remove reactive oxygen species. The degeneration and loss of presynapse cholinergic neurons in the brain tissue of patients with degenerative dementia were confirmed, and the results showed that cognitive impairment was improved when the central cholinergic function of actual degenerative dementia was enhanced.
퇴행성 치매의 약물 치료 목표는 인지 또는 행동 증상을 개선하고 질병의 진행을 지연시키거나 악화를 방지하는 것이다. 현재 퇴행성 치매의 치료제로 승인된 약물은 콜린에스터라제 저해제(cholinesterase inhibitor)로, 시냅스에서의 콜린 분해를 감소키시킴으로써 뇌에 작용하는 콜린을 증기시키는 기전을 갖는다. 대표적인 예로 타크린(tacrine, 상품명: Cognex), 리바스티그민(rivastigmine, 상품명: Exelon) 등과 같은 콜린에스터라제 저해제가 사용되고 있으나, 그 효과가 크지 않고 일시적으로 일부 증상을 호전시키는 정도의 효과를 나타내는 데 그치고 있다. 특히 타크린은 작용 시간이 짧고 투여량에 비례하여 간독성이 심하게 나타나며, 현훈, 위장관장애, 운동실조 등의 부작용도 나타내며, 리바스티그민은 주로 부교감 신경활성으로 인한 오심, 구토, 복통, 설사, 소화불량, 식욕부진, 어지로움, 초조, 우울, 두통, 불면, 혼동, 마비, 발한, 진전, 권태, 상호흡기와 생식기계 감염 등의 부작용이 있다. 최근 FDA에서 허가된 약품인 도네피질(donepezil, 상품명: Aricept)은 치매 초기 또는 중간 단계 환자에게 효과가 있는 것으로 알려져 있으나, 근육 경련, 피로감, 불면증, 운동장애, 현기증, 구토증, 설사 등의 부작용이 있다.The goal of drug treatment for degenerative dementia is to improve cognitive or behavioral symptoms, delay the progression of the disease, or prevent deterioration. Currently, a drug approved as a treatment for degenerative dementia is a cholinesterase inhibitor, which has a mechanism of vaporizing cholines acting on the brain by reducing choline breakdown in synapses. As a representative example, a choline esterase inhibitor such as tacrine (Cognex), rivastigmine (Exelon) and the like is used, but its effect is not so great and temporarily exhibits an effect of improving some symptoms It is stopping. In particular, tacrine has a short duration of action and a dose-dependent increase in hepatotoxicity. It also exhibits side effects such as dizziness, gastrointestinal disturbances, and ataxia. Ribasidin is mainly caused by nausea, vomiting, abdominal pain, diarrhea, There are side effects such as bad, anorexia, dizziness, irritability, depression, headache, insomnia, confusion, paralysis, sweating, tremor, boredom, respiratory and genital system infections. Donepezil (Aricept), a drug approved by the FDA, is known to be effective in patients with early or intermediate stages of dementia. However, side effects such as muscle spasms, fatigue, insomnia, movement disorders, dizziness, nausea and diarrhea have.
상기한 바와 같이, 현존 약물들은 퇴행성 치매 증상 치료 중 많은 부작용이 알려져 있어, 이와 같은 문제점을 해결할 수 있는 다른 원료의 치료제 개발이 절실한 상황이다.As described above, existing medicines are known to have many side effects in the treatment of symptoms of degenerative dementia, and it is urgent to develop therapeutic agents for other raw materials that can solve such problems.
본 발명이 해결하고자 하는 기술적 과제는 한약재를 이용하여 부작용이 최소화될 수 있으면서도 치매 예방 및 치료에 효과가 있는 건강차 조성물 및 건강차를 제공하는 것이다.The present invention provides a health tea composition and a health tea which are effective for prevention and treatment of dementia while minimizing side effects using herbal medicines.
이러한 과제를 해결하기 위하여 본 발명의 일 실시예에 따르면, 백작약, 천초, 차전자, 천궁, 백자인, 우슬, 육종용, 생지황, 백복신, 녹각, 석창포, 원지, 강황, 백출, 생강 및 대조를 포함하는 한약재를 이용한 건강차 조성물을 제공한다.In order to solve these problems, according to one embodiment of the present invention, there is provided a process for producing a starch, comprising the steps of: (1) preparing a starch, A health tea composition using a medicinal herb is provided.
상기 대조 100중량부에 대해 상기 백작약 70~90중량부, 상기 천초 30~50중량부, 상기 차전자 50~70중량부, 상기 천궁 70~90중량부, 상기 백자인 150~170중량부, 상기 우슬 70~90중량부, 상기 육종용 150~170중량부, 상기 생지황 70~90중량부, 상기 백복신 230~250중량부, 상기 녹각 230~250중량부, 상기 석창포 150~170중량부, 상기 원지 70~90중량부, 상기 강황 150~170중량부, 상기 백출 70~90중량부 및 상기 생강 90~110중량부를 포함할 수 있다.Wherein 70 to 90 parts by weight of the baux, 30 to 50 parts by weight of the baux, 50 to 70 parts by weight of the car electron, 70 to 90 parts by weight of the carass, 150 to 170 parts by weight of the white porcelain, 70 to 90 parts by weight of the green tea, 150 to 170 parts by weight of the green tea, 70 to 90 parts by weight of the raw green tea, 230 to 250 parts by weight of the white ginseng, 230 to 250 parts by weight of the green tea, 150 to 170 parts by weight of the seaweed, 90 to 90 parts by weight of the turmeric, and 90 to 110 parts by weight of the ginger.
육계, 황기, 택사, 지골피, 복분자, 남성, 목향, 인삼, 두충, 오미자, 구기자, 백복령, 파극, 산수유, 산약, 맥문동, 숙지황, 토사자, 용안육, 천문동, 감초 및 당귀 중 적어도 어느 하나를 더 포함할 수 있다.At least one of broccoli, hwanggi, taxa, phyllotaxis, bokbunja, male, horsetail, ginseng, mulberry, omija, gugija, Baekbokryeong, can do.
상기 대조 100중량부에 대해 상기 백작약, 육계 및 황기 혼합물 70~90중량부, 상기 천초 및 택사 혼합물 30~50중량부, 상기 차전자, 지골피 및 복분자 혼합물 50~70중량부, 상기 천궁 및 남성 혼합물 70~90중량부, 상기 백자인 150~170중량부, 상기 우슬, 목향, 인삼, 두충, 오미자, 구기자, 백복령, 파극, 산수유, 산약, 맥문동 및 숙지황 혼합물 70~90중량부, 상기 육종용, 토사자 및 용안육 혼합물 150~170중량부, 상기 생지황 및 천문동 혼합물 70~90중량부, 상기 백복신 230~250중량부, 상기 녹각 230~250중량부, 상기 석창포 150~170중량부, 상기 원지 70~90중량부, 상기 강황 및 백자인 혼합물 150~170중량부, 상기 백출, 감초 및 당귀 혼합물 70~90중량부 및 상기 생강 90~110중량부를 포함할 수 있다.70 to 90 parts by weight of the mixture of the vellus, broiler and vulcanizer, 30 to 50 parts by weight of the mixture of chrysanthemum and taxa, 50 to 70 parts by weight of the mixture of the car electron, 70 to 90 parts by weight of the white porcelain powder, 150 to 170 parts by weight of the white porcelain powder, 70 to 90 parts by weight of the mixture of wax, camphor, ginseng, mulberry, omija, gugija, A mixture of 150 to 170 parts by weight of a yin yang mixture, 70 to 90 parts by weight of a mixture of green beans and astrocanimide, 230 to 250 parts by weight of the white ginseng, 230 to 250 parts by weight of the green bean, 150 to 170 parts by weight of the seaweed, 150 to 170 parts by weight of the mixture of the sulfur and white porcelains, 70 to 90 parts by weight of the mixture of red ginseng, licorice and Angelica gigas, and 90 to 110 parts by weight of the ginger.
본 발명의 다른 실시예에 따르면, 상기 건강차 조성물을 물에 넣고 끓이거나, 분쇄한 가루 형태로서 음료에 녹이거나, 음료에 우려내어 제조된 한약재를 이용한 건강차를 제공한다.According to another embodiment of the present invention, there is provided a health tea using the herbal composition prepared by dissolving the health care composition in water as a powder form boiled or pulverized in water, or prepared with consideration for a beverage.
이상과 같이 본 발명의 실시예에 따른 한약재를 이용한 건강차 조성물 및 건강차는 부작용이 최소화될 수 있으면서 치매 예방 및 치료에 효과가 있다.As described above, the health tea composition and the health tea using the medicinal herb according to the embodiment of the present invention are effective in minimizing side effects while preventing and treating dementia.
도 1은 본 발명의 실시예에 따른 건강차 섭취 시 치매 증상 개선 정도를 나타낸 그래프이다.
도 2는 본 발명의 다른 실시예에 따른 건강차 섭취 시 치매 증상 개선 정도를 나타낸 그래프이다.FIG. 1 is a graph illustrating the degree of symptom improvement of dementia according to an embodiment of the present invention.
FIG. 2 is a graph showing the degree of symptom improvement of dementia when ingesting health tea according to another embodiment of the present invention.
이하에서 본 발명의 실시예에 대하여 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 상세히 설명한다. 그러나 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 실시예에 한정되지 않는다.Hereinafter, embodiments of the present invention will be described in detail so that those skilled in the art can easily carry out the present invention. The present invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein.
달리 정의되지 않는 한, 본 명세서에서 사용되는 모든 기술적 및 과학적 용어는 본 발명이 속하는 기술 분야의 숙련자에 의해 통상적으로 이해되는 바와 동일한 의미를 갖는다. 상충되는 경우, 정의를 포함하는 본 명세서가 우선할 것이다. 또한 본 명세서에서 설명되는 것과 유사하거나 동등한 방법 및 재료가 본 발명의 실시 또는 시험에 사용될 수 있지만, 적합한 방법 및 재료가 본 명세서에 기재된다.Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In case of conflict, the present specification, including definitions, will control. Also, although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, suitable methods and materials are described herein.
이하, 본 발명의 실시예에 따른 한약재를 이용한 건강차 조성물 및 건강차에 대해서 상세하게 설명한다.BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, a health tea composition and a health tea using a medicinal herb according to an embodiment of the present invention will be described in detail.
본 발명의 실시예에 따른 건강차 조성물은 백작약, 천초, 차전자, 천궁, 백자인, 우슬, 육종용, 생지황, 백복신, 녹각, 석창포, 원지, 강황, 백출, 생강 및 대조를 포함할 수 있다.The health tea composition according to an embodiment of the present invention may include a pesticide composition, a pomegranate, a chrysanthemum, a pomegranate, a white porcelain, a wax, a breeding, a raw pomegranate, a white gingiva, a pomegranate, a pomegranate, a pomegranate,
여기서, 백작약(Paeoniae radix Alba)은 작약과의 뿌리로서 주피를 제거한 후 삶아서 말린 것이고, 천초(Zanthoxylum bungeanum)는 초피나무의 열매이고, 차전자(psylium)는 질경이과에 속하는 여러해살이 초본 식물인 질경이의 종자이고, 천궁(Cnidium officinale makino)은 미나리과의 여러해살이풀이고, 백자인(Thujae semen)은 측백나무의 씨로서 그 껍질을 제거한 것이고, 우슬(Achyranthes japonica)은 비름과에 속하는 여러해살이 초본 식물인 쇠무릎의 뿌리이고, 육종용(cistanche deserticola)은 열당과의 육종용 또는 기타 동속 근연 식물의 육질경을 사용하여 만든 약재이고, 생지황(Rehmanniae radix recens)은 현삼과 식물인 지황의 뿌리이고, 백복신(Poria cocos)은 복령의 뿌리이고, 녹각(Cervi cornu)은 사슴과에 속하는 마녹 또는 매화녹 등 각종 사슴의 각질화된 뿔이고, 석창포(Acorus gramineus)는 천남성과의 석창포의 뿌리 줄기를 말린 약재이고, 원지(Polygalae radix)는 쌍떡잎식물 무환자나무목 원지과의 여러해살이풀의 뿌리이고, 강황(Curcuma longa)은 외떡잎식물 생강목 생강과의 한해살이풀이고, 백출(Atractylodes japonica)은 국화과의 삽주의 뿌리를 건조시킨 약재이고, 생강(Zingiber officinale)은 외떡잎식물 생강목 생강과의 여러해살이 풀이고, 대조(Zizyphus jujube var.inermis)는 갈매나무과 식물인 대추나무의 익은 열매를 말린 것이다.Here, the Paeoniae radix Alba is a root of the peony root, which is then boiled and dried. Zanthoxylum bungeanum is the fruit of the primate, and the psylium is the perennial herbaceous plant (Cnidium officinale makino) is a perennial plant of the perennial plant, Thujae semen is the seed of the perennial plant and its shell is removed. Achyranthes japonica is a perennial herbaceous plant , And cistanche deserticola is a medicinal substance made by using the meat quality of breeding or other relative plants of the herbaceous plant. Rehmanniae radix recens is a root of Rhizophorus rhizome, Poria cocos, (Cervi cornu) is the horned horn of various deer such as the carob or plum rust belonging to the deer, and Acorus gramineus The root (Polygalae radix) is a root of perennial plant of the dicotyledonous plant and the root of the perennial plant. Curcuma longa is an annual plant of the gingko gingiva of the dicotyledonous plant, Atractylodes japonica is a medicinal plant in which the roots of asteraceae are dried and the ginger (Zingiber officinale) is a perennial plant of ginger and ginger. The control (Zizyphus jujube var.inermis) It is dried fruit.
본 발명의 실시예에 따른 건강차 조성물은 대조 100중량부에 대해 백작약 70~90중량부, 천초 30~50중량부, 차전자 50~70중량부, 천궁 70~90중량부, 백자인 150~170중량부, 우슬 70~90중량부, 육종용 150~170중량부, 생지황 70~90중량부, 백복신 230~250중량부, 녹각 230~250중량부, 석창포 150~170중량부, 원지 70~90중량부, 강황 150~170중량부, 백출 70~90중량부 및 생강 90~110중량부를 포함할 수 있다.The health tea composition according to the present invention is characterized by comprising 70 to 90 parts by weight of Baekjang 70 to 90 parts by weight, 30 to 50 parts by weight per 30 seconds, 50 to 70 parts by weight of car electron, 70 to 90 parts by weight, 70 to 90 parts by weight of silkworm, 150 to 170 parts by weight of silkworm, 70 to 90 parts by weight of raw silkworm, 230 to 250 parts by weight of white ginseng, 230 to 250 parts by weight of green color, 150 to 170 parts by weight of silkworm, 150 to 170 parts by weight of turmeric, 70 to 90 parts by weight of flour, and 90 to 110 parts by weight of ginger.
이러한 함량으로 건강차 조성물을 구성할 때, 치매 예방 효과가 가장 우수하기 때문이다.This is because when the health tea composition is constituted with such a content, the dementing prevention effect is most excellent.
건강차 조성물은 상기 구성 재료들을 물에 넣고 장시간 끓여 마시거나, 혼합 분쇄한 가루 형태로서 물과 같은 식용 음료에 녹여서 마시거나, 티백 형태로서 물과 같은 식용 음료에 우려내어 섭취될 수 있다.The health tea composition can be ingested into edible beverages such as water, such as water, in the form of tea, or in the form of a tea bag, by dissolving the constituent materials in water and boiling them for a long time, or in a mixed and pulverized powder form.
본 발명의 다른 실시예에 따른 건강차 조성물은 상기 열거된 구성 성분 외에 육계, 황기, 택사, 지골피, 복분자, 남성, 목향, 인삼, 두충, 오미자, 구기자, 백복령, 파극, 산수유, 산약, 맥문동, 숙지황, 토사자, 용안육, 천문동, 감초 및 당귀 중 적어도 어느 하나를 더 포함할 수 있다.The health tea composition according to another embodiment of the present invention may further comprise at least one selected from the group consisting of broilers, hwanggi, taxa, giardia, bokbunja, males, ginseng, mugwort, omija, gugija, And can further include at least any one of Sukjanghwang, Tosa, Yongsan, Yukmun, Licorice, and Angelicae.
육계(Cercidiphyllum japonicum)는 녹나무과의 줄기 껍질로서 그대로 사용하거나 주피를 약간 제거한 것이고, 황기(Astragalus membranaceus)는 콩과에 속하는 다년생 초본식물이고, 택사(Alisma canaliculatum)는 늪이나 연못에 자라는 여러해살이 풀이고, 지골피(Lycium chinense)는 구기자나무 또는 기타 동속 식물의 뿌리 껍질을 말린 약재이고, 복분자(Rubus schizostylus)는 장미과의 갚잎떨기나무의 덜익은 열매이고, 남성(Arisaema amurense var. serratum)은 외떡잎식물 천남성목 천남성과의 여러해살이 풀이고, 목향(Inula helenium)은 국화과에 속하는 다년생 초본 식물이고, 인삼(Panax ginseng)은 다년생 초본의 뿌리 인삼이고, 두충(Eucommia ulmoides)은 쌍떡잎식물 장미목 두충과의 낙엽활엽 교목의 줄기 껍질로서 주피를 제거한 것이고, 오미자(Schisandra chinensis) 오미자 나무의 익은 열매이고, 구기자(Lycium chinense)는 구기자나무 또는 기타 동속식물의 열매이고, 백복령(Poria cocos)은 복령의 균핵으로 속에 소나무 뿌리가 박힌 것으로서 색이 흰 것이고, 파극(Morindae Radix) 파극천의 뿌리로서 수염뿌리를 제거하고 납작하게 눌러서 말린 것이고, 산수유(Cornus officinalis)는 산수유나무의 잘 익은 열매로서 씨를 제거한 것이고, 산약(Dioscorea batatas)은 마과 식물로서 마와 참마의 뿌리를 의미하고, 맥문동(Liriope platyphylla)은 외떡잎식물 백합목 백합과의 여러해살이 풀이고, 숙지황(Rehmannia glutinosa)은 현삼과 및 그 근연 식물의 뿌리를 그대로 또는 삶아 건조한 것이고, 토사자(Cuscuta japonica) 메꽃과에 속하는 한해살이 덩굴성 식물인 새삼의 씨앗이고, 용안육(Longan Arillus)은 용안의 헛씨껍질이고, 천문동(Asparagus cochinchinensis)은 백합과에 속하는 다년생 초본식물이고, 감초(Glycyrrhiza uralensis)는 콩과에 속하는 다년생 초본식물의 뿌리와 줄기 일부를 껍질이 붙은 채로, 또는 껍질을 벗긴 것이고, 당귀(Angelica uchiyamana)는 산형과 참당귀의 건조시킨 뿌리이다.The broiler (Cercidiphyllum japonicum) is used as a stem shell of camphoraceae and is slightly removed from juniper. Astragalus membranaceus is a perennial herbaceous plant belonging to the soybean family. Alisma canaliculatum is a perennial plant that grows in swamps and ponds. (Lycium chinense) is a medicinal herb that is dried on the root bark of Gujuza or other invertebrates. Rubus schizostylus is a less ripe fruit of the bushes of rosacea, and male (Arisaema amurense var. Serratum) (Inula helenium) is a perennial herbaceous plant belonging to Asteraceae, Panax ginseng is a perennial root ginseng, Eucommia ulmoides is a deciduous broad-leaved tree with dicotyledonous roots, It is the stem skin of the arboreal tree, and it is the ripe fruit of Schizandra chinensis (Schizandra chinensis) (Lycium chinense) is a fruit of Gugija or other genus, and Poria cocos is sclerotium of Bepyeong, which has a pine root embedded in it. It is white in color, and it removes the root of beard as Morindae Radix root Cornus officinalis is the ripe fruit of the Cornus officinalis, which is the seed removed. The Dioscorea batatas is the endemic plant, which means the root of the horseradish and yam, while the Liriope platyphylla is the endophytic plant lily Rehmannia glutinosa is a seed of the fresh ginseng which is an annual plant of the perennial plant of Cuscuta japonica, which is the dried root of the ginseng root and its related plants, (Longan Arillus) is a dead skin of a dragon, and Asparagus cochinchinensis is a perennial herbaceous plant belonging to the lily family, Second (Glycyrrhiza uralensis) will remain a part of the roots of perennial herbaceous plants belonging to Mesquite and the stem bark attached, or would peeled, Angelica (Angelica uchiyamana) is the dried root of Angelica gigas and dispersed.
본 발명의 다른 실시예에 따른 건강차 조성물은 대조 100중량부에 대해 백작약, 육계 및 황기 혼합물 70~90중량부, 천초 및 택사 혼합물 30~50중량부, 차전자, 지골피 및 복분자 혼합물 50~70중량부, 천궁 및 남성 혼합물 70~90중량부, 백자인 150~170중량부, 우슬, 목향, 인삼, 두충, 오미자, 구기자, 백복령, 파극, 산수유, 산약, 맥문동 및 숙지황 혼합물 70~90중량부, 육종용, 토사자 및 용안육 혼합물 150~170중량부, 생지황 및 천문동 혼합물 70~90중량부, 백복신 230~250중량부, 녹각 230~250중량부, 석창포 150~170중량부, 원지 70~90중량부, 강황 및 백자인 혼합물 150~170중량부, 백출, 감초 및 당귀 혼합물 70~90중량부 및 생강 90~110중량부를 포함할 수 있다.The health tea composition according to another embodiment of the present invention comprises 70 to 90 parts by weight of a mixture of a veterinary medicine, a broiler and a sulfur mixture, 30 to 50 parts by weight of a centipedial and a taxa mixture, 50 to 70 parts by weight of a tea, 70 to 90 parts by weight of a mixture of 70 to 90 parts by weight of a mixture of celery and a male, 150 to 170 parts by weight of white porcelain, wax, horseradish, ginseng, 70 to 90 parts by weight of a mixture of green beans and astronomic beans, 230 to 250 parts by weight of white ginseng, 230 to 250 parts by weight of green beans, 150 to 170 parts by weight of ground coffee, 70 to 90 parts by weight of ground bean, 150 to 170 parts by weight of a mixture of turmeric and white porcelain, 70 to 90 parts by weight of a mixture of liquorice, licorice and Angelica gigas, and 90 to 110 parts by weight of ginger.
이러한 함량으로 건강차 조성물을 구성할 때, 치매 예방 및 치료 효과가 가장 우수하기 때문이다.This is because when the health tea composition is constituted by such an amount, the effect of preventing and treating dementia is most excellent.
본 발명의 다른 실시예에 따른 건강차도 상기 구성 재료들을 물에 넣고 장시간 끓여 마시거나, 혼합 분쇄한 가루 형태로서 물과 같은 식용 음료에 녹여서 마시거나, 티백 형태로서 물과 같은 식용 음료에 우려내어 섭취될 수 있다.The health tea according to another embodiment of the present invention may also be prepared by dissolving the constituent materials in water and boiling them for a long time or mixing and crushing the same in an edible beverage such as water or drinking it in a teabag form, .
이하, 실시예를 통하여 본 발명의 구성 및 그에 따른 효과를 보다 상세히 설명하고자 한다. 그러나, 본 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것이며, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Hereinafter, the constitution of the present invention and the effect thereof will be described in more detail through examples. However, this embodiment is intended to explain the present invention more specifically, and the scope of the present invention is not limited to these embodiments.
실시예 1Example 1
백작약 80g, 천초 40g, 차전자 60g, 천궁 80g, 백자인 160g, 우슬 80g, 육종용 160g, 생지황 80g, 백복신 240g, 녹각 240g, 석창포 160g, 원지 80g, 강황 160g, 백출 80g, 생강 100g, 대조 100g을 포함하는 건강차 조성물을 물 10L에 넣고 2시간동안 끓여 건강차를 제조하였다.Includes 80g of pound, 40g of chest, 60g of tea, 80g of porridge, 160g of whiskey, 80g of ginseng, 160g of ginseng, 160g of raw persimmon, 80g of bamboo leaf, 240g of white ginseng, 240g of green tea, 160g of Seokchangpo, Was added to 10 L of water and boiled for 2 hours to prepare a health tea.
실시예 2Example 2
백작약, 육계 및 황기 혼합물 80g, 천초 및 택사 혼합물 40g, 차전자, 지골피 및 복분자 혼합물 60g, 천궁 및 남성 혼합물 80g, 백자인 160g, 우슬, 목향, 인삼, 두충, 오미자, 구기자, 백복령, 파극, 산수유, 산약, 맥문동 및 숙지황 혼합물 80g, 육종용, 토사자 및 용안육 혼합물 160g, 생지황 및 천문동 혼합물 80g, 백복신 240g, 녹각 240g, 석창포 160g, 원지 80g, 강황 및 백자인 혼합물 160g, 백출, 감초 및 당귀 혼합물 80g, 생강 100g 및 대조 100g를 포함하는 건강차 조성물을 물 10L에 넣고 2시간동안 끓여 건강차를 제조하였다.Gypsum, broccoli, gyuja, Baekbokryeong, coriander, coriander, ginseng mixture 80g, chrysanthemum and mixture 40g, 80 grams of mixture of green tea, ginseng and mushroom mixture, 80 grams of mixture of green tea, green tea and porcupine mixture, 160 grams of green tea mixture, 160 grams of mixture of green tea and lemon yoghurt, 80 grams of fresh persimmon and astronomical mixture, 80 g of white ginseng, 240 g of green tea, And 100 g of control was added to 10 L of water and boiled for 2 hours to prepare a health tea.
실험예Experimental Example
(1) BMC-Geriatrics 실험(1) BMC-Geriatrics experiment
치매 관련 증상 치료를 받은 평균 연령 67세의 남자 11명 및 여자 19명을 대상으로 3개월간 본 발명의 실시예 1 및 2에 따른 건강차를 하루에 500ml씩 복용시킨 후, 미국 배너 선 보건연구소(banner sun health research institute)에서 개발한 21가지 질문으로 구성되는 알츠하이머병 또는 치매의 전 단계인 기억상실성 경도인지장애를 확인하기 위한 설문지(BMC-Geriatrics)를 이용하여 인지 능력에 대한 실험을 진행하였다.11 men and 19 women of average age 67 years old treated with symptoms of dementia were administered with 500 ml of the health tea according to Examples 1 and 2 of the present invention for 3 months, (BMC-Geriatrics), a 21-question questionnaire developed by the banner sun health research institute, to identify cognitive impairments in the previous stages of Alzheimer's disease or dementia .
본 설문지는 15점이 넘을 경우 알츠하이머 혹은 치매로 판단하며, 5~14점일 경우 경도인지장애, 4점 이하인 경우 기억력에 문제가 없는 것으로 판정된다.The questionnaire is judged to be Alzheimer's disease or dementia when it is over 15 points, and it is judged that there is no problem in mild cognitive impairment when it is 5 ~ 14 points and memory problem when it is below 4 points.
이의 결과는 하기 표 1 및 도 1에 나타내었다.The results are shown in Table 1 and Fig.
표 1 및 도 1에 나타난 바와 같이 본 발명의 실시예에 따른 건강차를 복용한 경우 치매 증상이 개선되는 효과가 나타나는 것을 확인할 수 있었다.As shown in Table 1 and FIG. 1, when the health tea according to the example of the present invention was used, it was confirmed that the symptom of dementia was improved.
(2) 한국 인지 장애 선별 설문지 실험(2) Questionnaire test for Korean cognitive disorder
치매 관련 증상 치료를 받은 평균 연령 67세의 남자 11명 및 여자 19명을 대상으로 2개월간 본 발명의 실시예 1 및 2에 따른 건강차를 하루에 500ml씩 복용시킨 후, KDSQ(한국 인지 장애 선별 설문지)를 이용하여 실험을 진행하였다.11 male and 19 female patients of average age 67 years old who were treated with symptoms of dementia were administered with 500 ml of the health tea according to Examples 1 and 2 of the present invention for 2 months and then KDSQ The questionnaire was used to conduct the experiment.
본 설문지는 6점 이상인 경우 잠재적 치매 그룹으로 분류된다.This questionnaire is classified as a potential dementia group if the score is 6 or higher.
이의 결과는 하기 표 2 및 도 2에 나타내었다.The results are shown in Table 2 and FIG.
표 2 및 도 2에 나타난 바와 같이 본 발명의 실시예에 따른 건강차를 복용한 경우 치매 증상이 개선되는 효과가 나타나는 것을 확인할 수 있었다.As shown in Table 2 and FIG. 2, when the health tea according to the example of the present invention was used, it was confirmed that the symptom of dementia was improved.
이상과 같이 본 발명의 실시예에 따른 한약재를 이용한 건강차 조성물 및 건강차는 부작용이 최소화될 수 있으면서 치매 예방 및 치료에 효과가 있다.As described above, the health tea composition and the health tea using the medicinal herb according to the embodiment of the present invention are effective in minimizing side effects while preventing and treating dementia.
이상에서 본 발명의 바람직한 실시예에 대하여 상세하게 설명하였지만 본 발명의 권리범위는 이에 한정되는 것은 아니고 다음의 청구범위에서 정의하고 있는 본 발명의 기본 개념을 이용한 당업자의 여러 변형 및 개량 형태 또한 본 발명의 권리범위에 속하는 것이다.While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed exemplary embodiments, Of the right.
Claims (5)
상기 대조 100중량부에 대해 상기 백작약 70~90중량부, 상기 천초 30~50중량부, 상기 차전자 50~70중량부, 상기 천궁 70~90중량부, 상기 백자인 150~170중량부, 상기 우슬 70~90중량부, 상기 육종용 150~170중량부, 상기 생지황 70~90중량부, 상기 백복신 230~250중량부, 상기 녹각 230~250중량부, 상기 석창포 150~170중량부, 상기 원지 70~90중량부, 상기 강황 150~170중량부, 상기 백출 70~90중량부 및 상기 생강 90~110중량부를 포함하는 한약재를 이용한 건강차 조성물.The method of claim 1,
Wherein 70 to 90 parts by weight of the baux, 30 to 50 parts by weight of the baux, 50 to 70 parts by weight of the car electron, 70 to 90 parts by weight of the carass, 150 to 170 parts by weight of the white porcelain, 70 to 90 parts by weight of the green tea, 150 to 170 parts by weight of the green tea, 70 to 90 parts by weight of the raw green tea, 230 to 250 parts by weight of the white ginseng, 230 to 250 parts by weight of the green tea, 150 to 170 parts by weight of the seaweed, And 90 to 110 parts by weight of the ginger. The present invention relates to a health care composition comprising a herbal composition containing 90 to 90 parts by weight of the ginger, 150 to 170 parts by weight of the turmeric, 70 to 90 parts by weight of the ginger, and 90 to 110 parts by weight of the ginger.
육계, 황기, 택사, 지골피, 복분자, 남성, 목향, 인삼, 두충, 오미자, 구기자, 백복령, 파극, 산수유, 산약, 맥문동, 숙지황, 토사자, 용안육, 천문동, 감초 및 당귀 중 적어도 어느 하나를 더 포함하는 한약재를 이용한 건강차 조성물.The method of claim 1,
At least one of broccoli, hwanggi, taxa, phyllotaxis, bokbunja, male, horsetail, ginseng, mulberry, omija, gugija, Baekbokryeong, Wherein the composition comprises at least one compound selected from the group consisting of:
상기 대조 100중량부에 대해 상기 백작약, 육계 및 황기 혼합물 70~90중량부, 상기 천초 및 택사 혼합물 30~50중량부, 상기 차전자, 지골피 및 복분자 혼합물 50~70중량부, 상기 천궁 및 남성 혼합물 70~90중량부, 상기 백자인 150~170중량부, 상기 우슬, 목향, 인삼, 두충, 오미자, 구기자, 백복령, 파극, 산수유, 산약, 맥문동 및 숙지황 혼합물 70~90중량부, 상기 육종용, 토사자 및 용안육 혼합물 150~170중량부, 상기 생지황 및 천문동 혼합물 70~90중량부, 상기 백복신 230~250중량부, 상기 녹각 230~250중량부, 상기 석창포 150~170중량부, 상기 원지 70~90중량부, 상기 강황 및 백자인 혼합물 150~170중량부, 상기 백출, 감초 및 당귀 혼합물 70~90중량부 및 상기 생강 90~110중량부를 포함하는 한약재를 이용한 건강차 조성물.4. The method of claim 3,
70 to 90 parts by weight of the mixture of the vellus, broiler and vulcanizer, 30 to 50 parts by weight of the mixture of chrysanthemum and taxa, 50 to 70 parts by weight of the mixture of the car electron, 70 to 90 parts by weight of the white porcelain powder, 150 to 170 parts by weight of the white porcelain powder, 70 to 90 parts by weight of the mixture of wax, camphor, ginseng, mulberry, omija, gugija, A mixture of 150 to 170 parts by weight of a yin yang mixture, 70 to 90 parts by weight of a mixture of green beans and astrocanimide, 230 to 250 parts by weight of the white ginseng, 230 to 250 parts by weight of the green bean, 150 to 170 parts by weight of the seaweed, 150 to 170 parts by weight of a mixture of the above sulfuric acid and porcelain, 70 to 90 parts by weight of said mixture, said mixture of licorice and Angelica keiskei, and 90 to 110 parts by weight of said ginger.
A health tea comprising the herbal composition according to any one of claims 1 to 4 dissolved in a beverage in the form of boiled or ground powder in water, or a medicinal herb prepared from beverages.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170133432A KR20190041776A (en) | 2017-10-13 | 2017-10-13 | Health tea composition and health tea using medicinal herbs |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170133432A KR20190041776A (en) | 2017-10-13 | 2017-10-13 | Health tea composition and health tea using medicinal herbs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20190041776A true KR20190041776A (en) | 2019-04-23 |
Family
ID=66285132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020170133432A KR20190041776A (en) | 2017-10-13 | 2017-10-13 | Health tea composition and health tea using medicinal herbs |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20190041776A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110692770A (en) * | 2019-10-18 | 2020-01-17 | 北京九发药业有限公司 | Preparation method of instant Yanyou tea powder with health care effect |
-
2017
- 2017-10-13 KR KR1020170133432A patent/KR20190041776A/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110692770A (en) * | 2019-10-18 | 2020-01-17 | 北京九发药业有限公司 | Preparation method of instant Yanyou tea powder with health care effect |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60206137T2 (en) | HERBAL PLANTS CONTAINING MEDICINAL PRODUCTS | |
| CN105250675B (en) | A kind of Chinese medicine composition for being used to prepare the medicine for the treatment of tumour | |
| KR20190014376A (en) | Composition Comprising Sturgeon Extracts | |
| CN107372943A (en) | A kind of aid digestion pre- anti-halitosis health protection tea and its preparation method and application | |
| KR100968674B1 (en) | Herbal composition for alcoholic hangover | |
| KR102243873B1 (en) | Fermented pills for reducing and preventing premature dementia and manufacturing methods thereof | |
| KR20160131130A (en) | The herbal mixture extract as an active ingredient therapeutic compositions for mproving gastrointestinal disorders and indigestion and the therapeutic compositions manufactured thereby | |
| CN108126160B (en) | Traditional Chinese medicine composition, traditional Chinese medicine health tea, preparation method and application thereof | |
| KR20190041776A (en) | Health tea composition and health tea using medicinal herbs | |
| KR20170062781A (en) | Composition Comprising Black Ginseng Extract having Improving Activity of Cognitive Function | |
| CN104856920A (en) | Sleep facial mask capable of removing acne marks and preparation method of sleep facial mask | |
| CN1953760A (en) | Herbal formulation containing centella asiatica and sesamum indicum as brain tonic | |
| CN108653429A (en) | A kind of Chinese medicine composition that treating sty disease and its application | |
| KR20190041779A (en) | Health pill composition and health pill using medicinal herbs | |
| KR101167628B1 (en) | A composition comprising black ginseng for treating or preventing dementia and improving cognitive function | |
| CN107126535A (en) | The application process that plant extracts is cured the disease in tcm field, health, health care are new | |
| KR20180126231A (en) | A composition comprising herbal mixture extract for neuroprotection | |
| KR102127706B1 (en) | Preparation for improving blood circulation comprising mixed oriental medicinal extracts | |
| CN103828958A (en) | Novel weight-reducing tea and preparation method thereof | |
| KR20190041777A (en) | Health juice composition and health juice using medicinal herbs | |
| CN105920379A (en) | Traditional Chinese medicine eye cream to alleviate pouch and preparation method thereof | |
| CN105919907A (en) | Manufacturing method of traditional Chinese medicine eye cream and eye cream | |
| KR20190041778A (en) | Health soup composition and health soup using medicinal herbs | |
| CN104840773A (en) | Traditional Chinese medicine composition for treating vertebral artery type cervical spondylopathy and method for preparing same | |
| KR101914738B1 (en) | Composition for Preventing or Improving Dementia Comprising a Dried Flower Bud Powder and Root of Black Panax Ginseng |